Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PIVOTAL paediatric intensive care platform trial
ISRCTN22370354Phase 4Recruiting
- Sponsor
- Great Ormond Street Hospital
- Start
- Mar 2026
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of dexmedetomidine, clonidine and midazolam in critical illness (7 arms), sponsored by Great Ormond Street Hospital. Primary endpoints: Clinical outcome and Health economic outcome. Started Mar 2026; status: recruiting.
02
Drugs
dexmedetomidineclonidinemidazolam
03
Conditions
critical illness
Beyond the preview
Go deeper on ISRCTN22370354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN22370354.